VOGLOYD 3D (Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg))

Vogloyd 3D 2.3 Tablet Extended Release is classified among medications designed to manage diabetes. This specific formulation combines several active ingredients aimed at controlling blood sugar levels in adults diagnosed with type 2 diabetes mellitus. Administering this tablet during or just prior to meals is advisable to optimize its effectiveness. Consistency is key, so taking the medication at the same time every day is recommended. Your healthcare provider will determine the appropriate dosage based on your individual response and may adjust it over time in relation to your blood sugar readings. Continuing with this treatment is crucial, even if you feel well or your blood sugar levels appear stable. Abruptly discontinuing the medication without professional advice could lead to increased blood sugar, which poses significant risks including kidney damage, vision impairment, nerve complications, and even limb loss. It is important to note that this medication should complement a broader treatment strategy encompassing a balanced diet, regular physical activity, and weight management as recommended by your physician. Your lifestyle choices play a pivotal role in managing diabetes effectively. Awareness of symptoms indicating low blood glucose, such as shaking, dizziness, and sweating, is essential, alongside strategies for quick relief, like having accessible sources of sugar. Potential side effects may include nausea, vomiting, and abdominal discomfort, among others, which should be monitored.